Balance Sheet
Cash Flow Statement
Daily Values
DMA 100DMA 200DMA 50Dividend YieldEV to CFOEV to EBITEV to EBITDAEV to FCFEV to RevenueEnterprise ValueMarket Cap to FCFMarket CapitalizationPricePrice to EarningsPrice to Sales
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on Sales

Core Scientific (CORZ) Enterprise Value (2021 - 2026)

Core Scientific has reported Enterprise Value over the past 6 years, most recently at -$1.1 billion for Q1 2026.

  • Quarterly results put Enterprise Value at -$1.1 billion for Q1 2026, down 52.49% from a year ago — trailing twelve months through Mar 2026 was -$1.1 billion (down 52.49% YoY), and the annual figure for FY2025 was -$311.4 million, up 62.8%.
  • Enterprise Value reached -$1.1 billion in Q1 2026 per CORZ's latest filing, down from -$311.4 million in the prior quarter.
  • Across five years, Enterprise Value topped out at -$37.6 million in Q3 2022 and bottomed at -$1.1 billion in Q1 2026.
  • Median Enterprise Value over the past 5 years was -$140.4 million (2022), compared with a mean of -$311.6 million.
  • The largest annual shift saw Enterprise Value crashed 18181.06% in 2022 before it skyrocketed 81.55% in 2023.
  • Over 5 years, Enterprise Value stood at -$52.2 million in 2022, then plummeted by 33.44% to -$69.7 million in 2023, then crashed by 1100.68% to -$837.0 million in 2024, then surged by 62.8% to -$311.4 million in 2025, then plummeted by 242.15% to -$1.1 billion in 2026.
  • Business Quant data shows Enterprise Value for CORZ at -$1.1 billion in Q1 2026, -$311.4 million in Q4 2025, and -$453.4 million in Q3 2025.